Ariad Pharma Cash Flow - Annual (NASDAQ:ARIA)

Add to My Stocks
$23.99 $0 (0%) ARIA stock closing price Feb 16, 2017 (Closing)

The Ariad Pharma cash flow statement helps investors understand how well the company is managing its cash flows. Financials statements like the Ariad Pharma income statement and Ariad Pharma balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. The cash flow statement is essetial while conducting the Ariad Pharma cash flow analysis and can be used to measure the operating performance of Ariad Pharma compared to various industry peers like FGEN stock and NPSP stock. Ariad Pharma saw a outflow of $-17.2M from investing activities for 2015.

View details of Ariad Pharma cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec20152014201320122011201020092008
Net Income Cash Flow
-231.15M-162.6M-274.15M-220.87M-123.6M85.24M-80M-71.05M
Depreciation Depletion Amortization Cash-Flow12.75M8.81M4.13M8.3M4.61M6.14M4.19M2.63M
Net Increase (Decrease) in Assets Liabilities30.01M68.24M11.75M19.8M9.61M-110.82M10.61M15.01M
Cash From (used in) Discontinued Operations--------
Other Adjustments Net29.13M27.75M36.38M39.07M56.1M25.84M13.29M5.15M
Net Cash from (used by) Operating Activities
-159.24M-57.79M-221.88M-153.68M-53.26M6.41M-51.9M-48.25M
Increase (Decrease) in Prop Plant And Equipment-17.2M-2.78M-8.54M-4.42M-1.45M-1.34M-2.19M-6.65M
Acquisition Disposition of Subsidiaires--------
Increase (Decrease) in Investments--45M-45.05M--14.82M2.9M
Other Cash Inflow (Outflow) from Investment Activities-4.76M-10.31M-0.92M-0.67M-0.69M-1.35M-1.09M
Net Cash from (used by) Investment Activities
-17.2M1.98M26.13M-50.4M-2.12M-2.03M11.27M-4.83M
Issuance (Purchase) of Equity Shares4.43M31.27M316.32M22.99M255.92M60.92M58.93M-
Issuance (Repayment) of Debt Securities48.62M183.82M--1.45M2.9M-2.04M-1.48M9.08M
Increase (Decrease) in Bank & Other Borrowings--------
Payment of Dividends & Other Cash Distributions--------
Other Cash from (used by) Financing Activities1.19M-44.03M-3.36M-4.33M-0.82M---
Net Cash from (used by) Financing Activities
54.25M171.06M313.58M17.2M258.01M58.88M57.45M9.46M
Effect of Exchange Rate Changes on Cash---0.04M-----
Net Change in Cash & Cash Equivalents
-121.8M115.5M117.8M-186.87M202.62M63.26M16.81M-43.62M
Cash & Equivalents at Beginning of Year352.68M237.17M119.37M306.25M103.63M40.36M23.54M67.86M
Cash & Equivalents at Year End230.88M352.68M237.17M119.37M306.25M103.63M40.36M24.24M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Ariad Pharma stock price history and Ariad Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Ariad Pharma had a Net Change in Cash and Cash Equivalents of $-121.8M for the latest year 2015. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Ariad Pharma stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • The cash generated from the core business or operations was a negative at $-159.24M for Ariad Pharma in the latest 2015. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Cash from investing stood at a negative value of $-17.2M for ARIA stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $54.25M for Ariad Pharma.

Key Financial Ratios For Ariad Pharma Cash Flow